Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1978 ARTÍCULOS , VIENDO DEL 1831 AL 1845

Current Updates in Transdermal Therapeutic Systems and Their Role in Neurological Disorders

Yadav N, Mittal A, Ali J, Sahoo J.

Curr Protein Pept Sci. 2021;22(6):458-469. doi: 10.2174/1389203721999201111195512.

Cognitive Impairment in Older Adults and Therapeutic Strategies

Montine TJ, Bukhari SA, White LR.

Pharmacol Rev. 2021 Jan;73(1):152-162. doi: 10.1124/pharmrev.120.000031.

Advances in Stem Cell Therapy for Brain Diseases via the Intranasal Route

Dali P, Shende P.

Curr Pharm Biotechnol. 2021;22(11):1466-1481. doi: 10.2174/1389201021666201218130947.

Recent Evidence in Epigenomics and Proteomics Biomarkers for Early and Minimally Invasive Diagnosis of Alzheimer's and Parkinson's Diseases

Mayo S, Benito-León J, Peña-Bautista C, Baquero M, Cháfer-Pericás C.

Curr Neuropharmacol. 2021;19(8):1273-1303. doi: 10.2174/1570159X19666201223154009.

Environmental exposures and the etiopathogenesis of Alzheimer's disease: The potential role of BACE1 as a critical neurotoxic target

Syeda T, Cannon JR.

J Biochem Mol Toxicol. 2021 Apr;35(4):e22694. doi: 10.1002/jbt.22694. Epub 2021 Jan 4.

Coronavirus disease 2019 and neurodegenerative disease: what will the future bring?

McAlpine LS, Fesharaki-Zadeh A, Spudich S.

Curr Opin Psychiatry. 2021 Mar 1;34(2):177-185. doi: 10.1097/YCO.0000000000000688.

Parkinson´s and Alzheimer´s Diseases and Natural Products: Pathologies and Medication of the New Times

Nabavi SM, Sobarzo-Sánchez E.

Curr Neuropharmacol. 2021;19(2):112-113. doi: 10.2174/1570159X1902201231153120.

The Path to Progress Preclinical Studies of Age-Related Neurodegenerative Diseases: A Perspective on Rodent and hiPSC-Derived Models

MacDougall G, Brown LY, Kantor B, Chiba-Falek O.

Mol Ther. 2021 Mar 3;29(3):949-972. doi: 10.1016/j.ymthe.2021.01.001. Epub 2021 Jan 9.

GSK-3 Inhibitors: A New Class of Drugs for Alzheimer's Disease Treatment

Pal D, Mukherjee S, Song IH, Nimse SB.

Curr Drug Targets. 2021;22(15):1725-1737. doi: 10.2174/1389450122666210114095307.

Defining the Neuropathological Aggresome across in Silico, in Vitro, and ex Vivo Experiments

Gomes GN, Levine ZA.

J Phys Chem B. 2021 Mar 4;125(8):1974-1996. doi: 10.1021/acs.jpcb.0c09193. Epub 2021 Jan 19.

Deep Brain Stimulation in Alzheimer's Disease: Targeting the Nucleus Basalis of Meynert

Chen YS, Shu K, Kang HC.

J Alzheimers Dis. 2021;80(1):53-70. doi: 10.3233/JAD-201141.

Recent Advances in the Discovery of GSK-3 Inhibitors from Synthetic Origin in the Treatment of Neurological Disorders

Saha S, Pal D, Nimse SB.

Curr Drug Targets. 2021;22(12):1437-1462. doi: 10.2174/1389450122666210120143953.

Prevalence and Associated Factors of Visual Hallucinations in Patients with Vascular Cognitive Impairment

Chen CL, Hsu MH, Hung CH, Chiu PY, Liu CH.

Behav Neurol. 2021 Jan 9;2021:8866763. doi: 10.1155/2021/8866763. eCollection 2021.

Editorial to the Special Issue "Lipidomics and Neurodegenerative Diseases"

Calvano CD, Losito I, Cataldi T.

Int J Mol Sci. 2021 Jan 28;22(3):1270. doi: 10.3390/ijms22031270.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias